Photodynamic therapy for neovascularization in lipid keratopathy.

[Effectiveness of topical bevacizumab in bilateral primary lipid keratopathy].

CASE REPORT A 75-year-old man with bilateral idiopathic lipid keratopathy underwent a penetrating keratoplasty in the left eye. One month later, there was deep corneal neovascularisation extending across the bed and the graft-host interface, with a whitish opacity surrounding the vessels. Topical bevacizumab (25mg/mL) was administered 4 times daily for 2 months with partial regression of cornea...

Bilateral simultaneous anterior ischemic optic neuropathy in a young, healthy man.

tion With Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials—TAP Report 1 [published correction appears in Arch Ophthalmol. 2000;118:488]. Arch Ophthalmol. 1999; 117:1329-1345. 2. Verteporfin in Photodynamic Therapy Study Group. Verteporfin t...

Corneal Neovascularization with Associated Lipid Keratopathy in a Patient with Obstructive Sleep Apnea-Hypopnea Syndrome Using a Continuous Positive Airway Pressure Machine

OBJECTIVE To report a case of corneal neovascularization with secondary lipid keratopathy in a patient treated with continuous positive airway pressure (CPAP) for obstructive sleep apnea-hypopnea syndrome (OSAHS). CASE REPORT A 49-year-old male had been diagnosed with obstructive sleep apnea syndrome 10 years ago and has been treated with the application of a CPAP machine during night sleep e...

Cross-reference: MP-1.004 Cosmetic and Reconstructive Surgery MP-4.019 Oncological Applications of Photodynamic Therapy including Barrett's Esophagus MP-2.046 Ultraviolet Light Therapies MP-4.008 Photodynamic Therapy for Choroidal Neovascularization

Photodynamic therapy with verteporfin in subfoveal choroidal neovascularization secondary to central serous chorioretinopathy.

OBJECTIVE To examine the efficacy and safety of photodynamic therapy with verteporfin in the treatment of subfoveal choroidal neovascularization secondary to central serous chorioretinopathy (CSC). DESIGN Prospective interventional, noncomparative case series. METHODS After the diagnosis of a subfoveal choroidal neovascularization secondary to CSC, 26 eyes of 24 patients were treated with p...